Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Noncalcemic vitamin D analogue potently suppresses PTH in renal failure

Dec. 4, 2003

Imidazoline antidiabetic agent NNC-77-0020 modulates pancreatic hormone secretion

Dec. 4, 2003

Merck identifies estrogen ERalpha modulators useful in osteoporosis, cancer, etc.

Dec. 4, 2003

Wyeth scientists claim novel estrogen receptor modulators

Dec. 4, 2003

Novel IBAT inhibitors identified at AstraZeneca

Dec. 3, 2003

Approval to extend phase I trial of I.N.T.

Dec. 1, 2003

Nebido receives approval in Finland

Dec. 1, 2003

Takeda researchers prepare and test new squalene synthase inhibitors

Dec. 1, 2003

New approach to treatment of postmenopausal women

Dec. 1, 2003

Improved hemodynamic profile for new iron-containing hematinic agent ABT-870

Nov. 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...